Kyriazi Theo Melas is Director of Codiak BioSciences, Inc.. Currently has a direct ownership of 15,350 shares of CDAK, which is worth approximately $153. The most recent transaction as insider was on Feb 16, 2023, when has been sold 8,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.4K
0% 3M change
0% 12M change
Total Value Held $153

KYRIAZI THEO MELAS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2023
BUY
Exercise of conversion of derivative security
-
8,750 Added 36.31%
15,350 Common Stock
Oct 13 2020
BUY
Open market or private purchase
$99,000 $15.0 p/Share
6,600 Added 50.0%
6,600 Common Stock

Also insider at

EVLO
Evelo Biosciences, Inc. Healthcare
KLDO
Kaleido Biosciences, Inc. Healthcare
KTM

Kyriazi Theo Melas

Director
Cambridge, MA

Track Institutional and Insider Activities on CDAK

Follow Codiak BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDAK shares.

Notify only if

Insider Trading

Get notified when an Codiak Bio Sciences, Inc. insider buys or sells CDAK shares.

Notify only if

News

Receive news related to Codiak BioSciences, Inc.

Track Activities on CDAK